Quest Diagnostics SG&A remained flat by 0.0% to $504.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $476.00M to $504.00M. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 3.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
Metric ID:
selling_general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $429.00M | $427.00M | $464.00M | $425.00M | $422.00M | $464.00M | $563.00M | $439.00M | $416.00M | $380.00M | $407.00M | $440.00M | $416.00M | $448.00M | $466.00M | $476.00M | $486.00M | $501.00M | $504.00M | $504.00M |
| QoQ Change | — | -0.5% | +8.7% | -8.4% | -0.7% | +10.0% | +21.3% | -22.0% | -5.2% | -8.7% | +7.1% | +8.1% | -5.5% | +7.7% | +4.0% | +2.1% | +2.1% | +3.1% | +0.6% | +0.0% |
| YoY Change | — | — | — | — | -1.6% | +8.7% | +21.3% | +3.3% | -1.4% | -18.1% | -27.7% | +0.2% | +0.0% | +17.9% | +14.5% | +8.2% | +16.8% | +11.8% | +8.2% | +5.9% |
Range$380.00M – $563.00M
CAGR+3.5%
Avg YoY Growth+4.2%
Median YoY Growth+7.0%
Current Streak7 quarters growth
SG&A at Other Companies
Frequently Asked Questions
- What is Quest Diagnostics's sg&a?
- Quest Diagnostics (DGX) reported sg&a of $504.00M in Q1 2026.
- How has Quest Diagnostics's sg&a changed year-over-year?
- Quest Diagnostics's sg&a increased by 5.9% year-over-year, from $476.00M to $504.00M.
- What is the long-term trend for Quest Diagnostics's sg&a?
- Over 4 years (2021 to 2025), Quest Diagnostics's sg&a has grown at a 3.3% compound annual growth rate (CAGR), from $1.73B to $1.97B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.